Första AP-fonden’s Thermo Fisher Scientific TMO Stock Holding History

Första AP-fonden’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-82,610	Closed	-$47.9M	–	465
2025 Q4	$47.9M	Buy	82,610 +3,040	+4%	+$1.72M	0.29%	55
2025 Q3	$38.6M	Buy	79,570 +200	+0.3%	+$93.1K	0.23%	78
2025 Q2	$32.2M	Sell	79,370 -10,500	-12%	-$4.39M	0.21%	81
2025 Q1	$44.7M	Sell	89,870 -2,500	-3%	-$1.35M	0.34%	49
2024 Q4	$48.1M	Sell	92,370 -1,700	-2%	-$935K	0.34%	47
2024 Q3	$58.2M	Buy	94,070 +8,500	+10%	+$5.03M	0.45%	35
2024 Q2	$47.3M	Sell	85,570 -7,200	-8%	-$4.12M	0.42%	38
2024 Q1	$53.9M	Buy	92,770 +8,800	+10%	+$4.94M	0.46%	37
2023 Q4	$44.6M	Sell	83,970 -3,600	-4%	-$1.74M	0.45%	39
2023 Q3	$44.3M	Hold	87,570	–	–	0.49%	33
2023 Q2	$45.7M	Sell	87,570 -600	-0.7%	-$324K	0.49%	34
2023 Q1	$50.8M	Sell	88,170 -14,900	-14%	-$8.4M	0.6%	25
2022 Q4	$56.8M	Buy	103,070 +13,400	+15%	+$7.1M	0.64%	27
2022 Q3	$45.5M	Buy	89,670 +9,200	+11%	+$5.15M	0.56%	35
2022 Q2	$43.7M	Sell	80,470 -3,100	-4%	-$1.71M	0.57%	29
2022 Q1	$49.4M	Sell	83,570 -4,100	-5%	-$2.36M	0.56%	27
2021 Q4	$58.5M	Buy	87,670 +1,600	+2%	+$999K	0.59%	28
2021 Q3	$49.2M	Sell	86,070 -8,300	-9%	-$4.56M	0.56%	30
2021 Q2	$47.6M	Buy	94,370 +13,700	+17%	+$6.46M	0.56%	27
2021 Q1	$36.8M	Buy	80,670 +6,100	+8%	+$2.91M	0.52%	32
2020 Q4	$34.7M	Buy	74,570 +8,400	+13%	+$3.94M	0.52%	37
2020 Q3	$29.2M	Sell	66,170 -1,200	-2%	-$496K	0.6%	31
2020 Q2	$24.4M	Buy	67,370 +23,700	+54%	+$7.94M	0.64%	28
2020 Q1	$12.4M	Sell	43,670 -72,000	-62%	-$22.7M	0.44%	47
2019 Q4	$37.6M	Sell	115,670 -23,900	-17%	-$7.25M	1.87%	15
2019 Q3	$40.7M	Buy	139,570 +12,700	+10%	+$3.64M	1.7%	14
2019 Q2	$37.3M	Hold	126,870	–	–	1.68%	15
2019 Q1	$34.7M	Hold	126,870	–	–	1.53%	17
2018 Q4	$28.4M	Buy	126,870 +7,400	+6%	+$1.74M	1.35%	21
2018 Q3	$29.2M	Sell	119,470 -8,500	-7%	-$1.96M	1.17%	26
2018 Q2	$26.5M	Sell	127,970 -6,100	-5%	-$1.29M	1%	26
2018 Q1	$27.7M	Hold	134,070	–	–	0.96%	31
2017 Q4	$25.5M	Hold	134,070	–	–	0.93%	35
2017 Q3	$25.4M	Sell	134,070 -26,400	-16%	-$4.78M	0.89%	33
2017 Q2	$28M	Sell	160,470 -21,600	-12%	-$3.63M	0.78%	39
2017 Q1	$28M	Hold	182,070	–	–	0.9%	35
2016 Q4	$25.7M	Sell	182,070 -6,000	-3%	-$885K	0.83%	37
2016 Q3	$29.9M	Sell	188,070 -13,900	-7%	-$2.14M	0.83%	35
2016 Q2	$29.8M	Buy	+201,970	New	+$29.8M	0.87%	33

Other funds holding TMO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Första AP-fonden's TMO Position: Q1 2026 in Review

Första AP-fonden sold out of Thermo Fisher Scientific (TMO) in Q1 2026, closing a stake of 82,610 shares — an estimated $47.9M sold.

Första AP-fonden first reported a position in TMO in Q2 2016 and held it in 39 quarters. The position peaked at $58.5M in Q4 2021. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

Första AP-fonden reported no remaining Thermo Fisher Scientific position as of Q1 2026 after selling out during the quarter.
Första AP-fonden sold 82,610 Thermo Fisher Scientific shares in Q1 2026, an estimated $47.9M.
Första AP-fonden first reported a position in Thermo Fisher Scientific in Q2 2016 and held it in 39 quarters.
Första AP-fonden's Thermo Fisher Scientific position peaked at $58.5M in Q4 2021.
2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Första AP-fonden's 13F filing for Q1 2026.